JANX Stock Summary and Trading Ideas (Janux Therapeutics | NASDAQ:JANX)

Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. The proprietary technology of the company has enabled the development of distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr), Tumor Activated Immunomodulators (TRACIr), and Adaptive Immune Response Modulator (ARM) platforms. The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.

Janux Therapeutics trades on the NASDAQ stock market under the symbol JANX.

As of August 20, 2026, JANX stock price declined to $17.41 with 521,558 million shares trading.

JANX has a beta of 1.29, meaning it tends to be more sensitive to market movements. JANX has a correlation of 0.03 to the broad based SPY ETF.

JANX has a market cap of $1.06 billion. This is considered a Small Cap stock.

Last quarter Janux Therapeutics reported $10 million in Revenue and -$.35 earnings per share. This fell short of revenue expectation by $-12 million and missed earnings estimates by -$.07.

In the last 3 years, JANX traded as high as $71.71 and as low as $5.65.

The top ETF exchange traded funds that JANX belongs to (by Net Assets): XBI, IWM, VTI, VXF, IBB.

JANX has underperformed the market in the last year with a return of -29.5%, while SPY returned +20.5%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in JANX shares. However, JANX has outperformed the market in the last 3 month and 2 week periods, returning +26.1% and +8.8%, while SPY returned +4.3% and -0.8%, respectively. This indicates JANX has been having a stronger performance recently.

JANX support price is $16.98 and resistance is $18.06 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that JANX shares will trade within this expected range on the day.